Relative Age and the Use of Second-Generation Antipsychotics from 7 to 17 Years of Age: A Population-Based Register Study,Journal of Child and Adolescent Psychopharmacology

当前位置： X-MOL 学术 › J. Child Adolesc. Psychopharmacol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Relative Age and the Use of Second-Generation Antipsychotics from 7 to 17 Years of Age: A Population-Based Register Study
Journal of Child and Adolescent Psychopharmacology ( IF 1.9 ) Pub Date : 2022-02-14 , DOI: 10.1089/cap.2021.0053
Miika Vuori _{1,

2} , Andre Sourander _{2,

3} , Eeva T Aronen _{4,

5} , Kim Kronström _{2,

6} , Leena K Saastamoinen ₇

Affiliation

Objective: The youngest children in a classroom have a higher risk of attention-deficit/hyperactivity disorders (ADHDs) and depression than their relatively older peers. However, there has been a lack of research on how relative age is related to second-generation antipsychotic (SGA) medication use.

中文翻译：